Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L. Hauser, Ludwig Kappos, Amit Bar‐Or et al.|New England Journal of Medicine|2020Cited by 706
The contemporary spectrum of multiple sclerosis misdiagnosisAndrew Solomon, Brian G. Weinshenker, Dennis Bourdette et al.|Neurology|2016Cited by 324
Cell-based therapeutic strategies for multiple sclerosisNeil Scolding, Stefano Pluchino, Marcelo C. Pasquini et al.|Brain|2017Cited by 169
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.Anne H. Cross, Robert W. Karr|Journal of Clinical Investigation|1995Cited by 156
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Ludwig Kappos, Stephen L. Hauser et al.|Multiple Sclerosis Journal|2022Cited by 103